Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies April 24, 2024
- 4 Key Components to a Winning Go-To-Market Strategy April 24, 2024
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Veterinary Diagnostics: COVID-19 Pandemic Can’t Slow Momentum of $3.5 Billion Market
“The veterinary diagnostics market represents a fast-growing opportunity to IVD companies and others able to capitalize on the unfailing need to ensure agricultural productivity and the growth in consumer spending on companion animals.” – Kalorama Information The veterinary diagnostics market has experienced steady growth through the ravages of the pandemic and is forecast […]
11 Recent Developments in Cell and Gene Therapy as of March 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. The US Patent and Trademark Office has ruled against a patent challenge by the University of California, Berkeley (UC Berkeley) over patents awarded to the Broad Institute of MIT and […]
Tenfold Growth for $5.2 Billion Cell and Gene Therapy Market from 2021-2031
“Oncology, cardiovascular-blood and genetic conditions will be key contributors to the cell and gene therapy market’s strong performance through 2031.” – Kalorama Information It is an exciting and interesting time for companies involved in cell and gene therapy as the industry is forecast to grow tenfold between 2021 to 2031, according to leading medical […]
Funding for Cell and Gene Therapies Exceeded 70 Billion Last Year: Kalorama Report
Total funding from all sources for cell and gene therapy companies totaled $70.8 billion last year, according to a compilation of deals performed by Kalorama Information as part of its recent report. The growth in money being injected into cell and gene therapy companies continues to grow in 2022, according to the firm’s report: Cell […]
Cardiovascular Disease Pumps Sales of Cardiac Markers to $2,517 Million
“With the incidence of cardiovascular disease escalating, cardiac markers are in huge demand and a constant subject of research for improvement.” – Kalorama Information Despite improvements in treatment and increased public awareness about prevention, cardiovascular disease (CVD) is still the leading cause of death worldwide. CVD causes half of all deaths in several developed countries […]
10 Recent Developments in Cell and Gene Therapy
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Intellia Therapeutics, based in Cambridge, MA, has acquired Berkeley, CA-based Rewrite Therapeutics, a private biotech company specializing in developing novel genome editing technologies. Rewrite’s Rewriter platform utilizes CRISPR-guided DNA polymerases […]
Infographic: Blood Screening & Blood Transfusions
“The United States is the biggest user of blood transfusions—approximately 5 million people in the U.S. receive blood and blood components through 10.9 million transfusions per year.” – Kalorama Information The global $2.5 billion blood screening market is evolving on many levels, and despite it’s maturity the industry is poised for growth through 2026 […]
Coagulation Tests Near 4 Billion, Per IVD Newsletter
The 2021 global market for coagulation tests (lab-based and all POC) neared 4 billion last year. PT and d-dimer tests lead revenues, per Kalorama’s In Vitro Diagnostic Business Outlook. The publication focuses on one aspect of the IVD market in each issue. The publication comes out 2 times a month. This issue focused on […]
8 Recent Developments in Cell and Gene Therapy
There have been a number of recent developments in cell and gene therapy, as detailed in our bi monthly newsletter, Cell and Gene Therapy Business Outlook. New approvals in various countries, and technology licenses. Bristol-Myers Squibb K.K., a Tokyo-based subsidiary of Bristol-Myers Squibb (BMS), has announced that Japan’s Ministry of Health, Labour and Welfare has […]
Digital Pathology Gets Big
The global digital pathology market is valued at $866 million in 2021, consisting of hardware, software and related services for clinical applications. In 2020, markets experienced slowing demand early in the year due to reduced orders and budget freezes as the COVID-19 pandemic surged on over the year. The impact began to soften in the […]